Drug industry weakens US bill about disclosure of gifts

BMJ 2008; 336 doi: 10.1136/bmj.39598.476250.DB (Published 5 June 2008)
Cite this as: BMJ 2008;336:1268.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Bob Burton
  1. 1Hobart

    The US drug industry has persuaded key Congressional legislators to water down proposed legislation that would require detailed public disclosure of payments and gifts to doctors.

    In September 2007 the senators Chuck Grassley and Herb Kohl introduced the Physician Payments Sunshine Act 2007 to counter an estimated $19bn (£9.6bn; €12.3bn) spent a year courting doctors. At the time Mr Grassley told the Senate that “the best disinfectant” to payments to doctors was “sunshine,” which means openness.

    Benefits provided to doctors, he said, “can be a simple dinner after work, or they can add …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL